Top
Image Alt

The Investing Box

  /  Editor's Pick   /  AIM shares: 4 income stocks I’d buy for long-term rewards

AIM shares: 4 income stocks I’d buy for long-term rewards

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop

The following AIM shares provide something for both growth and dividend investors to celebrate. Here’s why I’d buy these small-cap income stocks for my Stocks and Shares ISA in 2023.

Ramsdens Holdings

Dividends forecasts for many UK shares appear in danger as the global economy cools. But pawnbroking specialist Ramsdens Holdings is one stock that should still be able to deliver robust shareholder payouts in the current climate. The yield here for 2023 sits at 4.3%.

Revenues at the small-cap jumped 62% in the 12 months to September as it recovered from the pandemic and the cost-of-living crisis worsened. It announced last week that trading in the first quarter of the current financial year had started robustly. The firm’s pawnbroking loan book continued to grow while gross profits at its jewellery retail business rose 15%.

A sharp fall in inflation could hamper Ramsden’s near-term profits growth. But as things stand the company looks set for another year of solid progress.

Alliance Pharma

Dividends from healthcare business Alliance Pharma grew strongly until they were cut during the pandemic. Annual payouts rose at least 10% in the nine years to 2018.

Shareholder rewards have grown again from 2020 and I’m expecting them to keep chugging higher. You see this share has a large portfolio of popular medical products like Kelo-Cote scar treatment gel and the Nizoral dandruff battler. And the business is gradually rolling out these winning brands in growth markets like China and the US.

I’d buy Alliance shares despite the huge competition that many of its products face. The dividend yield here for 2023 sits at 2.9%.

Sylvania Platinum

Buying shares in mining businesses like Sylvania Platinum can be a bumpy ride for investors. Their earnings are linked closely to the performance of commodity markets that can rise and fall sharply.

But as a long-term investor I find this South Africa-focused company highly appealing. This is because demand for the platinum group metals (or PGMs) it produces looks set to surge as the green economy expands.

The company’s metals are used to filter out harmful emissions from car exhaust systems. Platinum is also a key component in the production of green hydrogen. I’d buy Sylvania today too because of its bulky 6.7% dividend yield for 2023.

Begbies Traynor

Buying counter-cyclical companies like Begbies Traynor could be a good investment idea as the UK economy struggles. Latest financials showed revenues and adjusted pre-tax profits up 12% and 13% as demand for insolvency-related services jumped.

This is a stock I’d buy to hold for the long term. The company’s ambitious approach to acquisitions has driven prolonged double-digit annual earnings growth and could continue to do so. It has significant liquidity with which to pursue further investments.

I’d buy Begbies shares even though acquisition-led strategies can expose companies to unknown, profits-sapping risks. The dividend yield here sits at 2.6%.

The post AIM shares: 4 income stocks I’d buy for long-term rewards appeared first on The Motley Fool UK.

Don’t miss this top growth pick for the ‘cost of living crisis’

While the media raves about Google and Amazon, this lesser-known stock has quietly grown 880% – with a:

  • Greater than 20X increase in margins
  • Nearly 60% compounded revenue growth over 5 years – more than Apple, Amazon and Google!
  • A 3,000% earnings explosion

Of course, past performance is no guarantee of future results. However, we think it’s stronger now than ever before. Amazingly, you may never have heard of this company.

Yet there’s a 1-in-3 chance you’ve used one of its 250 brands. Many are household names with millions of monthly website visitors, and that often help consumers compare items, shop around and save.

Now, as the ‘cost of living crisis’ bites, we believe its influence could soar. And that might bring imminent new gains to investors who’re in position today. So please, don’t leave without your FREE report, ‘One Top Growth Stock from The Motley Fool’.

Claim your FREE copy now

setButtonColorDefaults(“#5FA85D”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43A24A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#FFFFFF”, ‘color’, ‘#FFFFFF’);
})()

More reading

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Alliance Pharma Plc and Begbies Traynor Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.